ZIMMER BIOMET HOLDINGS, INC. 8-K

What Happened

• Zimmer Biomet Holdings, Inc. announced on February 10, 2026 that it issued a press release reporting its financial results for the quarter and year ended December 31, 2025. The press release is attached to the Form 8-K and the information therein is incorporated by reference into the filing.

Key Details

• Filed Form 8-K on February 10, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• The press release covering quarterly and full-year results is included as Exhibit 99.1 to the 8-K.
• The filing also includes the Exhibit Index under Item 9.01; the report is signed by Chad F. Phipps, Senior Vice President, Chief Legal and Corporate Affairs Officer and Secretary.

Why It Matters

• This 8-K signals that Zimmer Biomet has publicly released its earnings and key financial metrics for Q4 and full-year 2025. Retail investors should review the attached press release (Exhibit 99.1) for revenue, earnings per share, margin and any commentary on results or outlook.
• The earnings release may affect analyst estimates and share price; for full context, compare the press release details with the company’s quarterly/annual filings and any accompanying earnings call or investor presentation.